Clinical trial
The Development of Minimally Invasive Nanosensor Technology to Quantify Mitochondrial Function in Human Muscle
NCT04086329 is registered in ClinicalTrials.gov with Children's Hospital of Philadelphia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Development of Minimally Invasive Nanosensor Technology to Quantify Mitochondrial Function in Human Muscle
- Lead sponsor
- Children's Hospital of Philadelphia
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 17, 2023
- Completion date
- August 1, 2027
- Enrollment
- 24 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.